Moderna Says Vaccine 100% Effective In Severe Cases, Seeks Clearance | Read
US firm Moderna said it would file requests for authorization of its Covid-19 vaccine in the United States and Europe on Monday. The company in a statement said while the full trial results confirmed a high efficacy estimated at 94.1 percent, the vaccine was 100 percent effective in severe cases.
